肝硬化合并门静脉血栓患者的差异蛋白筛选

熊静平; 彭媛媛; 张跃新

doi:10.3969/j.issn.1001-5256.2018.01.023

肝硬化合并门静脉血栓患者的差异蛋白筛选

DOI: 10.3969/j.issn.1001-5256.2018.01.023

1. 新疆医科大学第一附属医院感染疾病中心
2. 新疆医科大学第二附属医院消化科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2125
- HTML全文浏览量: 32
- PDF下载量: 438
- 被引次数: 0
出版历程
- 出版日期: 2018-01-20

Screening for differentially expressed proteins in patients with liver cirrhosis complicated by portal vein thrombosis

Infectious Disease Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China

摘要

摘要:
目的筛选肝硬化合并门静脉血栓形成（PVT）患者的血清差异表达蛋白。方法收集2015年11月-2016年11月在新疆医科大学第一附属医院感染疾病中心住院的45例肝硬化患者血清标本,其中合并PVT患者22例,无PVT患者23例。采用相对和绝对同位素定量标记（i TRAQ）联合色谱质谱技术筛选两组患者的血清差异蛋白,并对差异蛋白进行生物信息学分析。非正态分布的计量资料组间比较采用Mann-Whitney U检验;计数资料组间比较采用χ2检验。采用Fisher确切检验比较各个GO分类或KEGG通路在目标蛋白质集合和总体蛋白质集合中的分布情况,以此评价某个GO term或KEGG通路蛋白质富集度的显著性水平。结果共筛选出800个蛋白。有差异的蛋白86个,其中32个蛋白上调（ratio≥1.2,P<0.05）,54个蛋白下调（ratio≤0.83,P<0.05）。在这些蛋白中,有14类蛋白与细胞组分有关,22类蛋白与生化过程有关,10类蛋白与分子功能有关。使用KEGG分析发现肝硬化合并PVT组较无PVT组有18个蛋白在5个代谢和信号通路中有显著的差异。5个代谢和信...
- 肝硬化 /
- 静脉血栓形成 /
- 蛋白质组学
Abstract:
Objective To investigate the differentially expressed serum proteins in patients with liver cirrhosis complicated by portal vein thrombosis ( PVT) . Methods Serum samples were collected from 45 patients with liver cirrhosis who were hospitalized in Infectious Disease Center, The First Affiliated Hospital of Xinjiang Medical University, from November 2015 to November 2016, and among these patients, 22 had PVT and 23 had no PVT. Isobaric tags for relative and absolute quantitation ( i TRAQ) combined with chromatography and mass spectrometry were used to screen out the differentially expressed serum proteins, and a bioinformatics analysis was performed for the differentially expressed proteins. The Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups, and the chi-square test was used for comparison of categorical data between groups. The Fisher's exact test was used to compare the distribution of GO terms or KEGG pathways in the target protein set or total protein set, in order to evaluate the significance level of protein enrichment of a GO term or KEGG pathway. Results A total of 800 proteins were screened out, among which 86 were differentially expressed, including 32 upregulated proteins ( ratio ≥1. 2, P < 0. 05) and 54 downregulated proteins ( ratio ≤0. 83, P < 0. 05) . Among these proteins, 14 were associated with cellular component, 22 were involved in biochemical processes, and 10 were associated with molecular function. The KEGG analysis showed that there were significant differences in 18 proteins in 5 metabolic and signaling pathways between the liver cirrhosis-PVT group and liver cirrhosis group. These 5 metabolic and signaling pathways were associated with fat digestion and absorption, platelet activation, metabolism of glyoxylic acid and dicarboxylic acid, osteoclast differentiation, and axon guidance. Conclusion i TRAQ combined with chromatography and mass spectrometry can effectively screen out the differentially expressed serum proteins, among which GP5, FGA, and FGG may be potential biological markers for PVT in patients with liver cirrhosis and are worthy of further research.
- liver cirrhosis /
- venous thrombosis /
- proteomics

HTML全文

参考文献(16)

[1]OKUDA K, OHNISHI K, KINURA K, et al.Incidence of portal vein thrombosis in liver cirrhosis.An angiographic study in 708 patients[J].Gastroenterology, 1985, 89 (2) :279-286.

[2]CAGIN YF, ATAYAN Y, ERDOGAN MA, et al.Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients[J].Hepatobiliary Pancreat Dis Int, 2016, 15 (5) :499-503.

[3]LIU HM, GAO FY, YU H, et al.Screening of serum biomarkers by isobaric tags for relative and absolute quantitation in patients with HBV-related acute-on-chronic liver failure[J].Chin J Hepatol, 2016, 24 (8) :580-584. (in Chinese) 刘慧敏, 高方媛, 于浩, 等.基于同位素标记相对和绝对定量技术筛选乙型肝炎慢加急性肝衰竭患者的血清生物标志物[J].中华肝脏病杂志, 2016, 24 (8) :580-584.

[4]LI W, ZHANG X, WANG W, et al.Quantitative proteomics analysis of mitochondrial proteins in lung adenocarcinomas and normal lung tissue using i TRAQ and tandem mass spectrometry[J].Am J Transl Res, 2017, 9 (9) :3918-3934.

[5]ZENG L, ZHONG J, HE G, et al.Identification of Nucleobindin-2 as a potential biomarker for breast cancer metastasis using i TRAQ-based quantitative proteomic analysis[J].J Cancer, 2017, 8 (15) :3062-3069.

[6] GE JB, XU YJ, MEI CL, et al.Internal Medicine[M].8th ed.Beijing:People's Medical Publishing House, 2007:284-286. (in Chinese) 葛均波, 徐永健, 梅长林, 等.内科学[M].8版.北京:人民卫生出版社, 2007:284-286.

[7]CHROMY BA, EIDRIDGE A, FORSBERG JA, et al.Proteomic sample preparation for blast wound characterization[J].Proteome Sci, 2014, 12 (1) :10.

[8]SHAH K, THOMAS S, STEIN A.Affordable hands-on DNA sequencing and genotyping:an exercise for teaching DNA analysis to undergraduates[J].Biochem Mol Biol Educ, 2013, 41 (6) :388-395.

[9]HABIB AM, ISLAM MS, SOHEL M, et al.Mining the proteome of fusobacterium nucleatum subsp.nucleatum ATCC 25586 for potential therapeutics discovery:an in silico approach[J].Genomics Inform, 2016, 14 (4) :255-264.

[10]ZHAO D, LI HC, TAO HG, et al.Clinical diagnosis and treatment for portal vein thrombosis[J/CD].Chin J Hepatic Surg:Electronic Edition, 2017, 6 (1) :45-49. (in Chinese) 赵东, 李红春, 陶红光, 等.门静脉血栓形成的临床诊治分析[J/CD].中华肝脏外科手术学电子杂志, 2017, 6 (1) :45-49.

[11]QI X, HAN G, YE C, et al.Splenectomy causes 10-fold increased risk of portal venous system thrombosis in liver cirrhosis patients[J].Med Sci Monit, 2016, 22:2528-2550.

[12]ABDEL-RAZIK A, MOUSA N, ELHELALY R, et al.De-novo portal vein thrombosis in liver cirrhosis:risk factors and correlation with the Model for End-stage Liver Disease scoring system[J].Eur J Gastroenterol Hepatol, 2015, 27 (5) :585-592.

[13]MEI B, ZHENG K, CHEN XP.Relationship between platelets membrane glucoprotein CD62P with thrombosis of portal vein after devascularization operation[J].Acta Med Univ Sci Technol Huazhong, 2006, 35 (4) :548-549. (in Chinese) 梅斌, 郑凯, 陈孝平.断流术后门静脉血栓形成与血小板膜蛋白CD62P的关系[J].华中科技大学学报:医学版, 2006, 35 (4) :548-549.

[14]THOMAS MR, STOREY RF.The role of platelets in inflammation[J].Thromb Haemost, 2015, 114 (3) :449-458.

[15]FERNANDEZ-CADENAS I, PENALBA A, BOADA C, et al.Exome sequencing and clot lysis experiments demonstrate the R458C mutation of the alpha chain of fibrinogen to be associated with impaired fibrinolysis in a family with thrombophilia[J].J Atheroscler Thromb, 2016, 23 (4) :431-440.

[16]FOLSOM AR, TANG W, GEORGE KM, et al.Prospective study ofγ'fibrinogen and incident venous thromboembolism:the longitudinal investigation of thromboembolism etiology (LITE) [J].Thromb Res, 2016, 139:44-49.

施引文献

资源附件(0)

访问统计